Indolent prostate cancer and active surveillance Sue Mayor 1 January 2010 Grandround 0 Number 34 Download pdf article Early aggressive treatment in patients whose cancer is likely to progress slowly, if at all, causes side-effects and reduces their quality of life for no benefit. Can active surveillance avoid this? Download full article active surveillanceprostate cancer
Past events London (UK), 24/3/2017 – 4th ESO Prostate Cancer Observatory: innovation and care in the next 12 months Past events 28 January 2017 0
Featured Hereditary mutations in cancer: the use of panels and genetic counselling Featured, Grandround 25 May 2018 0
